Adam O'Dell, Author at Money & Markets, LLC

Author: Adam O'Dell

The Best Way to Win? Don’t Lose — A Low-Volatility Biotech Buy

Posted by Adam O'Dell | Jun 21, 2021 | Investing

The volatility factor helps you avoid the worst stock losers. This biotech company’s low volatility is a bonus as well.

Posted by Adam O'Dell | Jun 17, 2021 | Investing

You might think the entire biotech market segment carries more risk than, say, all consumer staples. Stock volatility may reveal an answer.

Posted by Adam O'Dell | Jun 15, 2021 | Investing

If you are looking for an inflation hedge, these three commodity ETFs are a safe bet.

Posted by Adam O'Dell | Jun 10, 2021 | Investing

We are heading into a commodities bull market. Supply and demand are not at equilibrium, and commodity prices will head higher until they are.

Posted by Adam O'Dell | Jun 7, 2021 | Investing

Venture capitalist Chamath Palihapitiya recently announced plans for four DNA SPACs, and that’s a huge deal for genomics stocks going forward.